The medical technology company Intelligent Bio Solutions Inc. (NASDAQ: INBS) is focused on providing fast, intelligent, and non-invasive testing solutions. The company noted that its Intelligent Fingerprinting Drug Screening System could help bring about a paradigm shift in portable testing through fingerprint sweat analysis.
There is also a belief within the company that the system could be deployed in other fields as well. Yesterday, the company came into focus after it announced that it had entered the New Zealand market. That was another major milestone for Intelligent Bio Solutions and its Intelligent Fingerprinting Drug Screening System. In New Zealand, the harm that is caused by drugs has an economic value of as much as $1.9 billion.
Considering the fact that the company managed to make a move into another major market, it may well be a good time to keep an eye on the Intelligent Bio stock. Additionally, considering the current levels of the stock, it could well be a major buying opportunity for investors. It could well be on the cusp of something big. Harry Simeonidis, the President and Chief Executive Officer of the company, spoke about the development as well.
He stated that everyone at the company was excited about the expansion into the market in New Zealand. He went on to note that it marked the completion of another significant growth milestone for Intelligent Bio Solutions. Earlier in October, the company announced that its system had in fact been adopted by the container logistics specialist firm VKVP Haulage.